Nothing Special   »   [go: up one dir, main page]

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (5,916)

Search Parameters:
Keywords = HIV-1

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 678 KiB  
Article
Implementation of Antigen-Based Diagnostic Assays for Detection of Histoplasmosis and Cryptococcosis among Patients with Advanced HIV in Trinidad and Tobago: A Cross-Sectional Study
by Ayanna Sebro, Jonathan Edwards, Omar Sued, Leon-Omari Lavia, Tricia Elder, Nadia Ram-Bhola, Roanna Morton-Williams Bynoe, Yanink Caro-Vega, Isshad John and Freddy Perez
J. Fungi 2024, 10(10), 695; https://doi.org/10.3390/jof10100695 (registering DOI) - 5 Oct 2024
Abstract
The Caribbean continues to have high HIV prevalence globally with concurrently high mortality rates due to opportunistic Infections. This study addresses the prevalence of histoplasmosis and cryptococcosis among patients living with advanced HIV disease (AHD) in Trinidad and Tobago, focusing on the implementation [...] Read more.
The Caribbean continues to have high HIV prevalence globally with concurrently high mortality rates due to opportunistic Infections. This study addresses the prevalence of histoplasmosis and cryptococcosis among patients living with advanced HIV disease (AHD) in Trinidad and Tobago, focusing on the implementation of antigen-based diagnostic assays. Conducted as a cross-sectional survey across five HIV treatment sites, 199 participants with advanced HIV disease were enrolled between July 2022 and September 2023. Diagnostic testing was performed using the Clarus Histoplasma Galactomannan Enzyme Immunoassay (EIA), and the Immy CrAg® LFA Cryptococcal Antigen Lateral Flow Assay on urine and blood samples, respectively. Results revealed that 14.6% of participants were found to be co-infected with either histoplasmosis or cryptococcosis, with histoplasmosis being more prevalent (10.5%) than cryptococcosis (4.0%). The study found no significant demographic differences between newly diagnosed and previously diagnosed participants. However, a lower median CD4 count was associated with a higher risk of fungal opportunistic infections. The findings underscore the critical role of systematic use of fungal antigen-based diagnostic assays among patients with AHD to improve the timely diagnosis and treatment of fungal infections among people living with HIV in resource-limited settings and to improve patient outcomes and survival. Full article
Show Figures

Figure 1

Figure 1
<p>Unadjusted 30-day survival curve of participants living with AHD following study enrolment.</p>
Full article ">Figure 2
<p>Unadjusted 30-day survival curve of participants living with AHD following study enrolment stratified by opportunistic infection diagnosis.</p>
Full article ">
12 pages, 1228 KiB  
Article
The Peculiar Emergence of Mpox (Monkeypox): Directions for the Search for the Natural Reservoir and Vaccination Strategies
by Romulus Breban
Vaccines 2024, 12(10), 1142; https://doi.org/10.3390/vaccines12101142 - 4 Oct 2024
Abstract
Background/Objectives: Mpox (monkeypox) is a zoonosis with origins in a currently unknown African reservoir. The first epidemiological accounts of mpox date back to the early 1980s, yet mpox only emerged as a pandemic threat in 2022–2023, more than 40 years later. This scenario [...] Read more.
Background/Objectives: Mpox (monkeypox) is a zoonosis with origins in a currently unknown African reservoir. The first epidemiological accounts of mpox date back to the early 1980s, yet mpox only emerged as a pandemic threat in 2022–2023, more than 40 years later. This scenario is very different from those of other emerging diseases such as HIV and SARS, which immediately spread globally, in fully susceptible populations, starting from patients zero. Methods: We use mathematical modeling to illustrate the dynamics of mpox herd immunity in small communities in touch with the mpox natural reservoir. In particular, we employ an stochastic model. Results: The peculiar emergence of mpox can be explained by its relationship with smallpox, which was eradicated through universal mass vaccination in 1980. Mpox first emerged in small rural communities in touch with mpox’s animal reservoir and then spread globally. The relative isolation of these communities and their herd-immunity dynamics against mpox worked to delay the introduction of mpox in large urban centers. Conclusions: Mathematical modeling suggests that the search for the mpox animal reservoir would be most fruitful in communities with high mpox seroprevalence and small outbreaks. These are communities is tight contact with the mpox natural reservoir. We propose vaccinating individuals in communities in these communities to severely reduce the importation of cases elsewhere. Full article
8 pages, 1445 KiB  
Article
Hepatitis Delta Virus Clade 8 Is the Predominant Clade Circulating in Botswana amongst People Living with HIV
by Kabo Baruti, Wonderful T. Choga, Patience C. Motshosi, Bonolo B. Phinius, Basetsana Phakedi, Lynnette N. Bhebhe, Gorata G. A. Mpebe, Chanana D. Tsayang, Tsholofelo Ratsoma, Tendani Gaolathe, Mosepele Mosepele, Joseph Makhema, Roger Shapiro, Shahin Lockman, Sikhulile Moyo, Mosimanegape Jongman, Motswedi Anderson and Simani Gaseitsiwe
Viruses 2024, 16(10), 1568; https://doi.org/10.3390/v16101568 - 4 Oct 2024
Abstract
Hepatitis delta virus (HDV) co-infections more often result in severe hepatitis compared to hepatitis B virus (HBV) infections alone. Despite a high HDV prevalence (7.1%), information regarding circulating HDV clades is very limited in Botswana. We extracted total nucleic acid from confirmed HDV-positive [...] Read more.
Hepatitis delta virus (HDV) co-infections more often result in severe hepatitis compared to hepatitis B virus (HBV) infections alone. Despite a high HDV prevalence (7.1%), information regarding circulating HDV clades is very limited in Botswana. We extracted total nucleic acid from confirmed HDV-positive samples and quantified their viral load. We then sequenced the large hepatitis delta antigen (L-HDAg) using Oxford Nanopore Technology (ONT). Genotyping was performed using the HDV Database, and HDV mutation profiling was performed on AliView. All participants with HBV genotypic information belonged to sub-genotype A1, and 80% (4/5) of them had a higher HDV viral load and a lower HBV viral load. We sequenced 75% (9/12) of the HDV-positive samples, which belonged to HDV clade 8. A total of 54 mutations were discovered, with the most prevalent being Q148R (16%), D149P (16%) and G151D (16%). Known mutations such as S117A, K131R, R139K and G151D were detected, while the other mutations were novel. Our results reveal that HDV clade 8 is the predominant clade in Botswana. The significance of all mutations remains unclear. Future studies with a larger sample size to detect other HDV clades that might be circulating in Botswana and functionally characterize the detected mutations are warranted. Full article
(This article belongs to the Section Human Virology and Viral Diseases)
Show Figures

Figure 1

Figure 1
<p>L-HDAg amino acid alignment of the isolates.</p>
Full article ">Figure 2
<p>Frequency of HDV mutations.</p>
Full article ">Figure 3
<p>HDV maximum likelihood phylogenetic tree.</p>
Full article ">
13 pages, 2386 KiB  
Article
Tsg101 UEV Interaction with Nedd4 HECT Relieves E3 Ligase Auto-Inhibition, Promoting HIV-1 Assembly and CA-SP1 Maturation Cleavage
by Susan M. Watanabe, David A. Nyenhuis, Mahfuz Khan, Lorna S. Ehrlich, Irene Ischenko, Michael D. Powell, Nico Tjandra and Carol A. Carter
Viruses 2024, 16(10), 1566; https://doi.org/10.3390/v16101566 - 2 Oct 2024
Abstract
Tsg101, a component of the endosomal sorting complex required for transport (ESCRT), is responsible for recognition of events requiring the machinery, as signaled by cargo tagging with ubiquitin (Ub), and for recruitment of downstream acting subunits to the site. Although much is known [...] Read more.
Tsg101, a component of the endosomal sorting complex required for transport (ESCRT), is responsible for recognition of events requiring the machinery, as signaled by cargo tagging with ubiquitin (Ub), and for recruitment of downstream acting subunits to the site. Although much is known about the latter function, little is known about its role in the earlier event. The N-terminal domain of Tsg101 is a structural homologue of Ub conjugases (E2 enzymes) and the protein associates with Ub ligases (E3 enzymes) that regulate several cellular processes including virus budding. A pocket in the domain recognizes a motif, PT/SAP, that permits its recruitment. PT/SAP disruption makes budding dependent on Nedd4L E3 ligases. Using HIV-1 encoding a PT/SAP mutation that makes budding Nedd4L-dependent, we identified as critical for rescue the residues in the catalytic (HECT) domain of the E3 enzyme that lie in proximity to sites in Tsg101 that bind Ub non-covalently. Mutation of these residues impaired rescue by Nedd4L but the same mutations had no apparent effect in the context of a Nedd4 isomer, Nedd4-2s, whose N-terminal (C2) domain is naturally truncated, precluding C2-HECT auto-inhibition. Surprisingly, like small molecules that disrupt Tsg101 Ub-binding, small molecules that interfered with Nedd4 substrate recognition arrested budding at an early stage, supporting the conclusion that Tsg101–Ub–Nedd4 interaction promotes enzyme activation and regulates Nedd4 signaling for viral egress. Tsg101 regulation of E3 ligases may underlie its broad ability to function as an effector in various cellular activities, including viral particle assembly and budding. Full article
Show Figures

Figure 1

Figure 1
<p><span class="html-italic">(</span><b>A</b>) Frequencies of contacts observed between the Tsg101 UEV domain and the HECT domain of Nedd4. Contact frequencies are derived from the top 10% of ensemble pairs taken from modeling of solution NMR paramagnetic relaxation enhancement experiments [<a href="#B20-viruses-16-01566" class="html-bibr">20</a>] for labels at sites 528 and 867 in the Nedd4 HECT domain (PDB ID: 57CJ, ”L” orientation shown). Contacts were defined as a residue of Tsg101 UEV coming within 4 Angstroms of the corresponding HECT residue, where HECT residue numbers are given both for Nedd4 (top) and the equivalent position in Nedd4L (bottom). Two regions with the most contacts; αH1 and the region proximal to the catalytic cysteine in the C-lobe are highlighted. As Tsg101 UEV is structurally homologous to an E2 enzyme, interaction in this region far from the canonical E2 binding site was unexpected. (<b>B</b>) A view of the Nedd4L HECT domain taken from PDB ID: 3JVZ highlighting the region around αH-1 (blue). The determinants in this region (Y601 and Y603) investigated here are highlighted in orange.</p>
Full article ">Figure 2
<p>Mutation of Nedd4L HECT residues in UEV proximity prevented virus rescue. (<b>A</b>) 293T cells were transfected with pNL4-LIRL alone (lanes 1,5) or co-transfected with 50–200 ng Nedd4L WT (lanes 2–4) or Nedd4L YY601,603AA mutant (lanes 6–8). Top panel, levels of VLP detected by Western blots; bottom panel, Gag p24 and p25 in cell lysates. (<b>B</b>) Western blot signals were quantified relative to the pNL4-LIRL samples with no Nedd4. Top panel, VLP produced when co-transfected with Nedd4L WT or YY601,603AA mutant; bottom panel, the ratio of Gag p24 and p25 levels in cell lysates co-transfected with Nedd4L WT or YY601,603AA. The levels of VLP produced and the ratio of Gag p24 and p25 in the cell lysate were significantly different when co-transfected with the Nedd4L Y601/Y603AA mutant versus Nedd4L WT (Student’s <span class="html-italic">t</span>-test, <span class="html-italic">p</span> &lt; 0.01). Number of independent trials, <span class="html-italic">n</span> = 2.</p>
Full article ">Figure 3
<p>C2 domain truncation compensated for mutation of HECT residues in UEV proximity. (<b>A</b>) 293T cells were transfected with pNL4-LIRL alone (lanes 1,5) or co-transfected with 50–200 ng Nedd4-2s WT which has a naturally occurring C2 domain truncation relative to Nedd4L (lanes 2–4) or Nedd4-2s YY601,603AA mutant (lanes 6–8). Top panel, levels of VLP detected by Western blots; bottom panel, Gag p24 and p25 produced in cell lysates. (<b>B</b>) Western blot signals from rescue assays were quantified relative to the pNL4-LIRL samples with no Nedd4-2s assayed in parallel. Top panel, VLP produced when co-transfected with Nedd4-2s WT or YY601,603AA mutant; bottom panel, Gag p24/p25 ratios in cell lysates co-transfected with Nedd4-2s WT or YY601,603AA. The increase in VLP production and the ratio of p24/p25 for Nedd4-2s YY601,603AA were not significantly different from Nedd4-2s WT (Student’s <span class="html-italic">t</span>-test, <span class="html-italic">p</span> &gt; 0.05). Number of independent trials, <span class="html-italic">n</span> = 2.</p>
Full article ">Figure 4
<p>Deletion of the HECT domain αH1 abrogates virus rescue. (<b>A</b>) 293T cells were transfected with pNL4-3-LIRL alone (lanes 1,5) or co-transfected with 50–200 ng Nedd4-2s WT (lanes 2–4) or Nedd4-2s-ΔαH1 (lanes 6–8). The Nedd4-2s constructs were compared for their ability to rescue pNL4-LIRL budding as measured by the levels of VLP detected by Western blots (top panel) and Gag p24 and p25 in cell lysates (bottom panel). (<b>B</b>) Western blot signals from rescue assays were quantified relative to the pNL4-LIRL samples with no Nedd4-2s assayed in parallel. Top panel, VLP produced when co-transfected with Nedd4-2s WT or Nedd4-2s-ΔαH1; bottom panel, the ratio of Gag p24 and p25 for Nedd4-2s WT or Nedd4-2s-ΔαH1. The VLP efficiency and the ratio of p24/p25 for ΔαH1 mutant were significantly different from WT (Student’s <span class="html-italic">t</span>-test, <span class="html-italic">p</span> &lt; 0.01). Number of independent trials, <span class="html-italic">n</span> = 2.</p>
Full article ">Figure 5
<p>Benserazide (K21) arrests budding of pNL4-3-P7L. (<b>A</b>) WST-1 assay of cell metabolic activity at increasing concentrations of K21 (CC50 110–140 µM, 95% CI); (<b>B</b>) Effect of K21 (50 µM) on VLP production. Top panel, Western analysis of virus-like particles (VLPs); bottom panel, Gag proteins in cell lysate for 293T cells transfected with pNL4-3 WT. (<b>C</b>) Effect of early versus late K21 (50 µM) addition on VLP production as determined by ELISA and MAGI assays (<span class="html-italic">n</span> = 2). Numbers were normalized to the untreated (DMSO) controls. (<b>D</b>) Examination by electron microscopy of mock, K21-treated cells, and Tenatoprazole-treated cells transfected with NL4-3-P7L (top). Bottom, Quantitative analysis of budding morphologies in cells exposed to either DMSO or 50 µM K21. For P7L, distribution of morphologies for control (DMSO) versus K21 were significantly different (Chi square test, <span class="html-italic">p</span> &lt; 0.001); for WT, distribution was not significantly affected by K21.</p>
Full article ">Figure 6
<p>Model: Tsg101 UEV interference with Nedd4 autoinhibition. Nedd4L is normally in an autoinhibited, inactive state (top left) induced by backbinding of the N-terminal C2 domain (blue) and WW domains (orange) to the catalytic HECT domain (gray). This form exists alongside the active form (top right), which may be induced by interaction of the Tsg101 UEV domain (pink), which in turn may interact with Ub (yellow) on the HECT domain or through direct interaction with the HECT domain or αH1 region (green). Amino acid substitutions in αH1 (bottom left) presumptively alleviates the autoinhibited state and Tsg101 interaction, similarly to the deletion of the entire αH1 region (bottom right). Mutation or deletion of αH1 has no impact on the Nedd4-2s isoform (right panel), whose truncated C2 domain putatively prevents backbinding and formation of the autoinhibited state. The Nedd4-2s isoform is distinct from the FL in its ability to interact with HIV-1 Gag, whose binding potentially affects helix-1 (far right, green).</p>
Full article ">
21 pages, 2235 KiB  
Article
Challenges and Solutions for Leave-One-Out Biosensor Design in the Context of a Rugged Fitness Landscape
by Shounak Banerjee, Keith Fraser, Donna E. Crone, Jinal C. Patel, Sarah E. Bondos and Christopher Bystroff
Sensors 2024, 24(19), 6380; https://doi.org/10.3390/s24196380 - 1 Oct 2024
Abstract
The leave-one-out (LOO) green fluorescent protein (GFP) approach to biosensor design combines computational protein design with split protein reconstitution. LOO-GFPs reversibly fold and gain fluorescence upon encountering the target peptide, which can be redefined by computational design of the LOO site. Such an [...] Read more.
The leave-one-out (LOO) green fluorescent protein (GFP) approach to biosensor design combines computational protein design with split protein reconstitution. LOO-GFPs reversibly fold and gain fluorescence upon encountering the target peptide, which can be redefined by computational design of the LOO site. Such an approach can be used to create reusable biosensors for the early detection of emerging biological threats. Enlightening biophysical inferences for nine LOO-GFP biosensor libraries are presented, with target sequences from dengue, influenza, or HIV, replacing beta strands 7, 8, or 11. An initially low hit rate was traced to components of the energy function, manifesting in the over-rewarding of over-tight side chain packing. Also, screening by colony picking required a low library complexity, but designing a biosensor against a peptide of at least 12 residues requires a high-complexity library. This double-bind was solved using a “piecemeal” iterative design strategy. Also, designed LOO-GFPs fluoresced in the unbound state due to unwanted dimerization, but this was solved by fusing a fully functional prototype LOO-GFP to a fiber-forming protein, Drosophila ultrabithorax, creating a biosensor fiber. One influenza hemagglutinin biosensor is characterized here in detail, showing a shifted excitation/emission spectrum, a micromolar affinity for the target peptide, and an unexpected photo-switching ability. Full article
(This article belongs to the Special Issue Fluorescence Sensors for Biological and Medical Applications)
12 pages, 1663 KiB  
Article
Influence of Hematocrit and Storage Temperature on the Stability of Dried Blood Samples in Serological Analyses of Tetanus, Diphtheria, and Pertussis
by Mariano Rodríguez-Mateos, Silvia Carlos, Javier Jaso, África Holguín and Gabriel Reina
Diagnostics 2024, 14(19), 2195; https://doi.org/10.3390/diagnostics14192195 - 1 Oct 2024
Abstract
Background: Dried blood spots (DBSs) enable the study of serological markers of various pathogens without the need to obtain serum/plasma through venipuncture. Methods: Sixty-four blood samples were prepared on Whatman™ 903 cards using specimens obtained by venipuncture to study the detection of serological [...] Read more.
Background: Dried blood spots (DBSs) enable the study of serological markers of various pathogens without the need to obtain serum/plasma through venipuncture. Methods: Sixty-four blood samples were prepared on Whatman™ 903 cards using specimens obtained by venipuncture to study the detection of serological markers of diphtheria, tetanus, and pertussis in DBSs, and their stability 4 months post-collection. An automated chemiluminescent immunoassay was used to investigate diphtheria, tetanus, and pertussis IgG levels from both DBSs and plasma samples. Results: An optimal cut-off value for DBSs was calculated to improve the performance of diphtheria and tetanus serological markers in DBSs, achieving high sensitivity (95% and 98%, respectively) and specificity (91.7% and 92.3%, respectively). No protection against pertussis was found in the population studied. The correlation observed between the plasma and the DBSs processed after sample collection was high (0.967–0.970) for all antibodies studied except pertussis (0.753), both considering hematocrit before sample elution or not. The correlation between DBSs and plasma for diphtheria and tetanus remained strong following a 4-month delay in DBS processing at 4 °C (0.925–0.964) and −20 °C (0.924–0.966), with only a minor decrease observed for diphtheria at room temperature (0.889), while maintaining a strong correlation for tetanus (0.960). For pertussis, the correlation between DBSs and plasma was drastically reduced after delaying its processing for 4 months at any temperature. Conclusions: To summarize, hematocrit levels within the normal range do not affect the processing of DBSs in the study of serological markers of diphtheria, tetanus, and pertussis. The DBS stability for serological diagnosis of diphtheria and tetanus is adequate when samples are stored at −20 °C for a period of 4 months. The pertussis serological marker does not appear to remain stable after 4 months, even when the DBS is stored frozen at −20 °C. Full article
(This article belongs to the Special Issue Advances in the Diagnosis of Infectious Diseases and Microorganisms)
Show Figures

Figure 1

Figure 1
<p>Processing and storage conditions of DBSs and plasma for serological diagnosis. PBS: phosphate-buffered saline; DBS-A: DBS processed immediately and eluted by adjusting the volume of PBS taking the hematocrit value into account; DBS-B: DBS immediately and eluted with 1 mL of PBS regardless of the hematocrit; DBS-C: DBS stored at −20 °C for 4 months; DBS-D: DBS stored at 4 °C for 4 months; DBS-E: DBS stored at room temperature for 4 months.</p>
Full article ">Figure 2
<p>Comparison of DBS and plasma results for diphtheria, tetanus, and pertussis, processed immediately following sample collection. DBS-A: DBS eluted with a volume of PBS considering hematocrit; DBS-B: DBS eluted with 1 mL of PBS regardless of hematocrit.</p>
Full article ">Figure 3
<p>Immunity (IgG) against diphtheria and tetanus in our study population calculated using the manufacturer cut-off values for plasma (&gt;0.01 IU/mL for diphtheria and &gt;0.1 IU/mL for tetanus) and the optimized DBS cut-off values for all DBS analysis (&gt;0.028 IU/mL for diphtheria and &gt;0.243 IU/mL for tetanus). DBS-A: DBS processed immediately and eluted with a volume of PBS based on the hematocrit; DBS-B: DBS processed immediately and eluted with 1 mL of PBS; DBS-C: DBS stored at −20 °C for 4 months; DBS-D: DBS stored at 4 °C for 4 months; DBS-E: DBS stored at room temperature for 4 months.</p>
Full article ">
22 pages, 956 KiB  
Review
The Management of Hematopoietic Stem Cell Transplant in People with HIV
by Jana K. Dickter and Courtney Moc Willeford
Viruses 2024, 16(10), 1560; https://doi.org/10.3390/v16101560 - 30 Sep 2024
Abstract
Hematopoietic stem cell transplant (HSCT) is now recognized as a standard treatment option for people with HIV (PWH) who develop high-risk hematologic malignancies. However, the involved polypharmacy can lead to complications from drug interactions and toxicities, affecting the efficacy and safety of chemotherapy [...] Read more.
Hematopoietic stem cell transplant (HSCT) is now recognized as a standard treatment option for people with HIV (PWH) who develop high-risk hematologic malignancies. However, the involved polypharmacy can lead to complications from drug interactions and toxicities, affecting the efficacy and safety of chemotherapy and antiretroviral therapy (ART). Managing these patients requires a personalized approach, including the careful selection of ART based on previous therapies and potential interactions, alongside risk assessment for infections. This discussion will address the history of HSCT in PWH and management considerations for this group. Full article
14 pages, 247 KiB  
Article
COVID-19 Stress Is Associated with Increased Smoking among People with HIV in Western Washington: A Cross-Sectional Survey
by Anh Tuyet Nguyen, Francis Slaughter, Sarah Smith, David A. Katz, Sandeep Prabhu, Liying Wang, Jane M. Simoni, Judith I. Tsui and Susan M. Graham
COVID 2024, 4(10), 1617-1630; https://doi.org/10.3390/covid4100112 - 30 Sep 2024
Abstract
Background. People living with HIV (PWH) frequently have co-morbid substance use disorders that may have been impacted by the COVID-19 pandemic. This study examined associations between COVID-related stress and increased substance use among PWH in Washington State. Methods. Between August 2020 and March [...] Read more.
Background. People living with HIV (PWH) frequently have co-morbid substance use disorders that may have been impacted by the COVID-19 pandemic. This study examined associations between COVID-related stress and increased substance use among PWH in Washington State. Methods. Between August 2020 and March 2021, we conducted an online survey of 397 PWH in western Washington. Logistic regression was used to analyze associations between a COVID-19 stress score and four self-reported outcomes: increased alcohol use, increased cigarette smoking, increased marijuana use, and increased use of illicit substances. Results. Thirty-five (38.0%) of 92 participants who smoked, 61 (23.4%) of 261 participants who used alcohol, 15 (14.6%) of 103 participants who used marijuana, and 35 (33.0%) of 102 participants who used illicit substances reported increased use of these substances. Higher COVID-19 stress scores were associated with higher odds of increased cigarette smoking (adjusted odds ratio [aOR] = 1.15, 95% confidence interval [CI]: 1.04–1.27), even after adjustment for anxiety and depressive symptoms (aOR 1.14, 95%CI: 1.03–1.27). COVID-19 stress was not associated with an increased use of alcohol, marijuana, or illicit substances. Conclusions. COVID-19-related stress was associated with self-reported increased cigarette smoking among PWH in western Washington during the pandemic. Full article
8 pages, 591 KiB  
Brief Report
Performance of Elecsys® HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection
by Prooksa Ananchuensook, Jongkonnee Wongpiyabovorn, Anchalee Avihingsanon and Pisit Tangkijvanich
Diagnostics 2024, 14(19), 2179; https://doi.org/10.3390/diagnostics14192179 - 29 Sep 2024
Abstract
Background/Objectives: The Elecsys® HCV Duo immunoassay (Roche Diagnostics International Ltd., Rotkreuz, Switzerland) detects both antibodies to hepatitis C virus (anti-HCV) and HCV core antigen (HCV-Ag) and has shown excellent diagnostic performance in blood donor samples. We aim to validate its use for [...] Read more.
Background/Objectives: The Elecsys® HCV Duo immunoassay (Roche Diagnostics International Ltd., Rotkreuz, Switzerland) detects both antibodies to hepatitis C virus (anti-HCV) and HCV core antigen (HCV-Ag) and has shown excellent diagnostic performance in blood donor samples. We aim to validate its use for diagnosing chronic HCV infection and assessing sustained virological response (SVR) post-direct-acting antivirals (DAAs) in patients with or without HIV infection. Methods: Blood samples from 100 healthy controls, as well as 64 HCV mono-infection and 136 HCV-HIV coinfections, were collected before and 12–24 weeks after DAAs. The assay performance for determining active infection at baseline and SVR was compared with HCV RNA. Results: Overall, 156 (78.0%) of HCV-infected patients had HCV genotype 1, and the SVR rate was 96.5%. The sensitivity, specificity, and area under the ROC curve (AUROC) for HCV diagnosis at baseline were 99.50% (95% confidence interval [CI], 96.82–99.97%), 100% (95%CI, 95.39–100%), and 0.998 (95%CI, 0.992–1.003), respectively. The corresponding results for HCV-Ag in determining SVR were 57.14% (95%CI, 20.24–88.19%), 97.41% (95%CI, 93.73–99.04%), and 0.773 (95%CI, 0.543–1.003), respectively. The assay also exhibited comparable sensitivity and specificity between HCV mono- and coinfection. Conclusions: Our study showed that the Elecsys® HCV Duo immunoassay effectively diagnosed HCV infection, regardless of HIV status, making it suitable for managing high-risk populations in resource-limited settings. Full article
(This article belongs to the Section Diagnostic Microbiology and Infectious Disease)
Show Figures

Figure 1

Figure 1
<p>Proposed clinical application of Elecsys<sup>®</sup> HCV Duo immunoassay. HCV, hepatitis C virus; anti-HCV, HCV antibodies; HCV-Ag, HCV core antigen.</p>
Full article ">
16 pages, 1666 KiB  
Study Protocol
Oral Pre-Exposure Prophylaxis Innovative Interventions among Adolescent Girls and Young Women in South Africa: A Protocol Paper
by Lerato Lucia Olifant, Edith Phalane and Refilwe Nancy Phaswana-Mafuya
Methods Protoc. 2024, 7(5), 77; https://doi.org/10.3390/mps7050077 - 29 Sep 2024
Abstract
Although South Africa was the first country to register and roll out oral pre-exposure prophylaxis (PrEP) biomedical human immunodeficiency virus (HIV) prevention intervention in sub-Saharan Africa (SSA), its uptake remains low, particularly among adolescent girls and young women (AGYW). The uptake of PrEP [...] Read more.
Although South Africa was the first country to register and roll out oral pre-exposure prophylaxis (PrEP) biomedical human immunodeficiency virus (HIV) prevention intervention in sub-Saharan Africa (SSA), its uptake remains low, particularly among adolescent girls and young women (AGYW). The uptake of PrEP may have worsened during the Coronavirus disease 2019 (COVID-19) pandemic. Some innovative interventions to improve PrEP uptake among AGYW have been implemented. This study aims to evaluate the effectiveness of PrEP innovative interventions implemented during COVID-19 towards reducing the risk of HIV infection among AGYW in South Africa. An exploratory, descriptive design will be conducted to carry out four study objectives. Firstly, to carry out a systematic review of innovative PrEP interventions implemented during COVID-19 in SSA countries. Secondly, to conduct a stakeholder analysis to identify PrEP stakeholders and interview them on their views on the implemented interventions. Thirdly, to assess the implementation outcomes of the innovative interventions using document reviews and Consolidated Framework for Implementation Research. Fourthly, to develop a framework for an improved PrEP service delivery among AGYW. Qualitative data will be captured in ATLAS.ti software (Technical University, Berlin, Germany) version 23 and analysed via thematic analysis. A statistical software package (STATA) version 18 (College Station, TX, USA) will be used to capture quantitative data and analyse them via descriptive analysis. The generated evidence will be used towards the development of framework, guidelines, and policies to strengthen the uptake of, scale-up, and adherence to PrEP among AGYW. Full article
(This article belongs to the Section Public Health Research)
Show Figures

Figure 1

Figure 1
<p>PRISMA flow diagram adapted from Page et al. [<a href="#B25-mps-07-00077" class="html-bibr">25</a>].</p>
Full article ">Figure 2
<p>Summary of data sources that will be used in the study.</p>
Full article ">
9 pages, 1564 KiB  
Brief Report
Cerebrospinal Fluid and Peripheral Blood Lymphomonocyte Single-Cell Transcriptomics in a Subject with Multiple Sclerosis Acutely Infected with HIV
by Carmela Pinnetti, Gabriella Rozera, Francesco Messina, Pietro Giorgio Spezia, Elisabetta Lazzari, Lavinia Fabeni, Giovanni Chillemi, Daniele Pietrucci, Shalom Haggiag, Ilaria Mastrorosa, Alessandra Vergori, Enrico Girardi, Andrea Antinori, Fabrizio Maggi and Isabella Abbate
Int. J. Mol. Sci. 2024, 25(19), 10459; https://doi.org/10.3390/ijms251910459 - 28 Sep 2024
Abstract
Signatures of neurodegeneration in clinical samples from a subject with multiple sclerosis (MS) acutely infected with HIV were investigated with single-cell transcriptomics using 10X Chromium technology. Sequencing was carried out on NovaSeq-TM, and the analysis was performed with Cell Ranger software (v 7.1.0) [...] Read more.
Signatures of neurodegeneration in clinical samples from a subject with multiple sclerosis (MS) acutely infected with HIV were investigated with single-cell transcriptomics using 10X Chromium technology. Sequencing was carried out on NovaSeq-TM, and the analysis was performed with Cell Ranger software (v 7.1.0) associated with a specifically established bioinformatic pipeline. A total of 1446 single-cell transcriptomes in cerebrospinal fluid (CSF) and 4647 in peripheral blood mononuclear cells (PBMCs) were obtained. In the CSF, many T-cell lymphocytes with an enriched amount of plasma cells and plasmacytoid dendritic (pDC) cells, as compared to the PBMCs, were detected. An unsupervised cluster analysis, putting together our patient transcriptomes with those of a publicly available MS scRNA-seq dataset, showed up-regulated microglial neurodegenerative gene expression in four clusters, two of which included our subject’s transcriptomes. A few HIV-1 transcripts were found only in the CD4 central memory T-cells of the CSF compartment, mapping to the gag-pol, vpu, and env regions. Our data, which describe the signs of neurodegenerative gene expression in a very peculiar clinical situation, did not distinguish the cause between multiple sclerosis and HIV infection, but they can give a glimpse of the high degree of resolution that may be obtained by the single-cell transcriptomic approach. Full article
(This article belongs to the Special Issue New Insights into the Immunopathology of Infectious Diseases)
Show Figures

Figure 1

Figure 1
<p>Uniform manifold approximation and projection (UMAP) plots representing cell clusters identified in patient’s CSF and PBMC single-cell transcriptomes. Color-coded cell clusters derived from single-cell transcriptomic analysis of CSF (<b>A</b>) and PBMC (<b>B</b>) samples are shown. To assess the cellular identity of each cluster, canonical cell markers were used (see <a href="#sec4-ijms-25-10459" class="html-sec">Section 4</a>).</p>
Full article ">Figure 2
<p>Uniform manifold approximation and projection (UMAP) plots representing 0–15 clusters identified in unsupervised cluster analysis performed on the total CSF and PBMC transcriptomes. The 16 identified clusters are shown using different colors (see legend on the right) and the arrows indicate those displaying up-regulated neurodegenerative microglial gene expression.</p>
Full article ">Figure 3
<p>Alignment track of HIV transcripts in single cells from the CSF across the annotated HIV subtype G (KU168277). On the top, the HIV reference sequence and annotated genes (in dark blue) are displayed. (A–C): the read coverage and stacked individual reads, represented as arrows, are shown in different panels enlarged below. Different colors within the reads highlight present nucleotide variations compared to the reference sequence: red is used for T, green is used for A, orange is used for G, and blue for C. Picture obtained from the IGV Web App.</p>
Full article ">
25 pages, 5680 KiB  
Review
The Assembly of HTLV-1—How Does It Differ from HIV-1?
by Dominik Herrmann, Shuyu Meng, Huixin Yang, Louis M. Mansky and Jamil S. Saad
Viruses 2024, 16(10), 1528; https://doi.org/10.3390/v16101528 - 27 Sep 2024
Abstract
Retroviral assembly is a highly coordinated step in the replication cycle. The process is initiated when the newly synthesized Gag and Gag-Pol polyproteins are directed to the inner leaflet of the plasma membrane (PM), where they facilitate the budding and release of immature [...] Read more.
Retroviral assembly is a highly coordinated step in the replication cycle. The process is initiated when the newly synthesized Gag and Gag-Pol polyproteins are directed to the inner leaflet of the plasma membrane (PM), where they facilitate the budding and release of immature viral particles. Extensive research over the years has provided crucial insights into the molecular determinants of this assembly step. It is established that Gag targeting and binding to the PM is mediated by interactions of the matrix (MA) domain and acidic phospholipids such as phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2). This binding event, along with binding to viral RNA, initiates oligomerization of Gag on the PM, a process mediated by the capsid (CA) domain. Much of the previous studies have focused on human immunodeficiency virus type 1 (HIV-1). Although the general steps of retroviral replication are consistent across different retroviruses, comparative studies revealed notable differences in the structure and function of viral components. In this review, we present recent findings on the assembly mechanisms of Human T-cell leukemia virus type 1 and highlight key differences from HIV-1, focusing particularly on the molecular determinants of Gag–PM interactions and CA assembly. Full article
Show Figures

Figure 1

Figure 1
<p>HTLV-1 and HTLV-1 replication cycles. (<b>A</b>) Mature HTLV-1 virion attaches to the host cell receptor complex containing NRP-1, GLUT-1, and HSPGs. The mechanisms of reverse transcription and uncoating have long been thought to occur in the cytoplasm but recent advances on the mechanisms of HIV-1 reverse transcription and uncoating (below) raised similar questions about other retroviruses, including HTLV-1. Subsequent nuclear import and integration into the host genome yields the provirus. Transcription and translation produce Gag, Gag-Pol, Env, accessory proteins, and viral gRNA. Gag is trafficked to the PM for assembly via the MTOC, while Env is post-translationally processed and trafficked to the cell surface through the ER and Golgi apparatus. Virus assembly and maturation yield a new, infectious virus. (<b>B</b>) Mature HIV-1 virion attaches to the host CD4 receptor and co-receptors (CCR5 or CXCR4). The virus core is then transported to the nucleus via microtubules, a process that appears to be accompanied by reverse transcription. Recent studies indicated that CA core uncoating occurs in the nucleus near the integration sites. Transcription and translation produce Gag, Gag-Pol, Env, accessory proteins, and viral gRNA. Gag is then trafficked to the PM for assembly, while Env is post-translationally processed and trafficked to the cell surface through the ER and Golgi apparatus. Virus assembly and maturation yield a new, infectious virus.</p>
Full article ">Figure 2
<p>HTLV-1 genome and RNA transcripts. Genome encodes for Gag, Pro, Pol, Env, Tax, Rex, and pX genes. pX region contains genes of Rex, Tax, p30, p12, p13, and HBZ (antisense transcript). mRNA transcripts are 5′-capped and 3′-polyadenylated. Alternative splicing yields mRNA for Env, Tax, Rex, p12, p13, p30, and HBZ.</p>
Full article ">Figure 3
<p>MA-membrane binding models for HIV-1 and HTLV-1. (<b>A</b>) Structures of HIV-1 myrMA (PDB code 2H3I) and HTLV-1 myr(–)MA (PDB code 7M1W). Structures highlight the HBR implicated in membrane binding (blue sticks). For HIV-1 myrMA, the following residues are not shown for clarity: myr group, residues 2–3 and 115–132. For HTLV-1 myr(–)MA, the following residues are not shown for clarity: 1–2 and 94–99. (<b>B</b>) Surface representation of the HIV-1 myrMA structure (PDB code 2H3I) highlighting residues that exhibited substantial chemical shift changes upon binding of <span class="html-italic">tr</span>-P(4,5)P<sub>2</sub> (PDB code 2H3V) and IP<sub>3</sub> (left and middle, respectively). Structures are viewed in identical orientations. The structure of HTLV-1 myr(–)MA bound to IP<sub>3</sub> is shown on the right. (<b>C</b>) Models of HIV-1 myrMA and HTLV-1 myr(–)MA bound to membrane showing interactions between PI(4,5)P<sub>2</sub> and/or PS and the HBR. Membrane bilayer was constructed by CHARMM-GUI [<a href="#B169-viruses-16-01528" class="html-bibr">169</a>].</p>
Full article ">Figure 4
<p>HIV-1 and HTLV-1 Gag hexamer structures. (<b>A</b>) The two HIV-1 CA molecules are displayed on the side of the hexamer, with CA<sub>NTD</sub> in cyan and CA<sub>CTD</sub> in orange. HIV-1 SP1 domains are shown in blue. The PDB codes are HIV-1 (5L93) [<a href="#B109-viruses-16-01528" class="html-bibr">109</a>], HTLV-1 CA<sub>NTD</sub> (8PUG) [<a href="#B183-viruses-16-01528" class="html-bibr">183</a>], and HTLV-1 CA<sub>CTD</sub> (8PUH) [<a href="#B183-viruses-16-01528" class="html-bibr">183</a>]. The cross-section of the HTLV-1 Gag lattice reconstruction map suggests a distinctive arrangement of the CA<sub>NTD</sub> and CA<sub>CTD</sub> compared to HIV-1. (<b>B</b>) Shown is the top view of the HIV-1 hexamer structure, which was generated by fitting HIV-1 CA (5L93) into the EM density of the immature HIV-1 lattice (EMD: 4017). The top view of the HTLV-1 Gag hexamer structure shown was generated by fitting CA<sub>NTD</sub> and CA<sub>CTD</sub> separately into the EM density of the immature HTLV-1 CA lattice (EMD: 17942). The flexible linker between HTLV-1 CA<sub>NTD</sub> and CA<sub>CTD</sub> is unstructured and is therefore not shown.</p>
Full article ">Figure 5
<p>Comparison of Env CT. (<b>A</b>) Schematic representation of the gp41 subunits, indicating the lengths of their respective cytoplasmic tails (25 and 150 amino acids for HTLV-1 and HIV-1, respectively. (<b>B</b>) Secondary structure representation of the HIV-1 gp41CT protein based on the NMR data [<a href="#B192-viruses-16-01528" class="html-bibr">192</a>]. (<b>C</b>) HIV-1 Env incorporation is mediated by interaction between the MA domain of the Gag lattice and gp41CT. For HTLV-1, the CT appears to contain functional motifs that play important roles in cell-to-cell infection and syncytium formation.</p>
Full article ">Figure 6
<p>Comparison of MA lattices based on structural data. (<b>A</b>) Schematic representation of the myrMA lattice in the immature and mature states based on the cryo-ET data [<a href="#B170-viruses-16-01528" class="html-bibr">170</a>]. The trimer–trimer interactions are mediated by the N-terminal domain in the vicinity of the myr group, while the PI(4,5)P<sub>2</sub> binding pocket is empty. In the mature myrMA lattice, PI(4,5)P<sub>2</sub> is bound to the cleft and myrMA trimer–trimer interactions are formed by the HBR and PI(4,5)P<sub>2</sub>. (<b>B</b>) Schematic illustration of the myrMA lattice based on the X-ray structure of myrMA. In this lattice, myrMA–myrMA interaction at the trimer–trimer interface is mediated by the N-terminal residues. Of note, myrMA–myrMA interaction at the trimer–trimer interface places the myr groups (red) in juxtaposition. The HBR and PI(4,5)P<sub>2</sub> binding cleft are also shown. Hexagons and triangles denote C6 and C3 symmetry, respectively.</p>
Full article ">
10 pages, 749 KiB  
Article
The Resurgence of Treponema pallidum Infections and Reinfections during the COVID-19 Pandemic in Greece
by Andreas G. Tsantes, Panagiotis Toumasis, Aglaia Domouchtsidou, Electra Nicolaidou, Stefanos Bonovas, Alexander Stratigos, Athanasios Tsakris and Georgia Vrioni
Int. J. Environ. Res. Public Health 2024, 21(10), 1283; https://doi.org/10.3390/ijerph21101283 - 26 Sep 2024
Abstract
The beginning of the COVID-19 pandemic was marked by a sharp decline in syphilis infections in many countries worldwide, including Greece. However, a resurgence of positive cases started to appear in the second half of 2020. The aim of this study was to [...] Read more.
The beginning of the COVID-19 pandemic was marked by a sharp decline in syphilis infections in many countries worldwide, including Greece. However, a resurgence of positive cases started to appear in the second half of 2020. The aim of this study was to explore the impact of the pandemic on the incidence of new syphilis infections and reinfections and analyze the sociodemographic characteristics associated with recurrent episodes. We analyzed medical records from a 14-month period after the beginning of the pandemic and compared them with the respective period before the start of the pandemic. Our participants consisted mainly of men, with a median age of 43 years, homosexual orientation, and higher education. During COVID-19, more HIV patients presented for syphilis testing (38.0% vs. 34.6%, p = 0.025). Overall, we observed almost a two-fold increase in positive syphilis cases during COVID-19 (21.1% vs. 12.4%, p < 0.001), with new infections rising from 8.4% to 13.2% and reinfections from 4.0% to 7.9%. Multivariable logistic regression analysis revealed that the COVID-19 pandemic, among different parameters (such as age, gender, sexual orientation, HIV status, and educational level), was the only factor associated with higher positive syphilis rates (OR 1.47, 95% CI: 1.07–2.01, p = 0.003). Our results highlight the need to ensure enhanced prevention and undisrupted healthcare services, with a focus on future pandemics. Full article
Show Figures

Figure 1

Figure 1
<p>Positive and negative syphilis cases before and during the COVID-19 period.</p>
Full article ">Figure 2
<p>Incidence rates of syphilis and HIV in the population over the study period.</p>
Full article ">
10 pages, 580 KiB  
Article
Treatment Outcomes of Tuberculosis Among Artisanal and Small-Scale Miners in Zimbabwe: A Follow-Up Observational Study Using Secondary Data
by Dingani Moyo, Fungai Kavenga, Ronald Thulani Ncube, Florence Moyo, Nathan Chiboyiwa, Andrew Nyambo, Godknows Madziva, Mpokiseng Ncube, Orippa Muzvidziwa, Tafadzwa Mperi, Blessings Chigaraza, Victoria Varaidzo Chizana, Plassey Ropafadzo Chinove, Frank Mudzingwa, Kudzaishe Mutungamiri and Collins Timire
Int. J. Environ. Res. Public Health 2024, 21(10), 1282; https://doi.org/10.3390/ijerph21101282 - 26 Sep 2024
Abstract
In Zimbabwe, artisanal and small-scale miners (ASMs) are a key vulnerable group with high risk for tuberculosis (TB), HIV, and silicosis. The main purpose of this study was to investigate treatment outcomes of TB among ASMs. We conducted a follow-up observational study using [...] Read more.
In Zimbabwe, artisanal and small-scale miners (ASMs) are a key vulnerable group with high risk for tuberculosis (TB), HIV, and silicosis. The main purpose of this study was to investigate treatment outcomes of TB among ASMs. We conducted a follow-up observational study using secondary data. We analyzed data from 208 ASMs treated for TB at two occupational health clinics. We found a high treatment success rate of 87%, comparable to the national average for drug-sensitive TB. Unsuccessful outcomes were due to death (5%) and loss to follow-up (7%). Over a quarter of ASMs had unknown HIV status. Our study is the first to document treatment outcomes of TB among ASMs in Zimbabwe. Encouragingly, this study demonstrates the possibility of achieving good TB treatment outcomes even among highly mobile populations like ASMs. Further research is needed to analyze leakages across the whole TB patient pathway among ASMs. Additionally, addressing the high rate of unknown HIV statuses among ASMs is crucial to further improve overall TB treatment outcomes in this population. Full article
Show Figures

Figure 1

Figure 1
<p>Sampling procedure for study participants for the two OHCs.</p>
Full article ">
14 pages, 631 KiB  
Review
Entangled Connections: HIV and HPV Interplay in Cervical Cancer—A Comprehensive Review
by Giuliana Pavone, Andrea Marino, Viviana Fisicaro, Lucia Motta, Alessandra Spata, Federica Martorana, Serena Spampinato, Benedetto Maurizio Celesia, Bruno Cacopardo, Paolo Vigneri and Giuseppe Nunnari
Int. J. Mol. Sci. 2024, 25(19), 10358; https://doi.org/10.3390/ijms251910358 - 26 Sep 2024
Abstract
Cervical cancer (CC) remains a prevalent malignancy and a significant global public health concern, primarily driven by persistent human papillomavirus (HPV) infections. The infectious nature of HPV underscores the preventability of CC through vaccination and screening programs. In addition to HPV, factors such [...] Read more.
Cervical cancer (CC) remains a prevalent malignancy and a significant global public health concern, primarily driven by persistent human papillomavirus (HPV) infections. The infectious nature of HPV underscores the preventability of CC through vaccination and screening programs. In addition to HPV, factors such as age, parity, smoking, hormonal contraceptives, and HIV co-infection elevate the risk of CC. HIV-associated immunodeficiency exacerbates susceptibility to infections and cancers, making CC a defining condition for acquired immune deficiency syndrome (AIDS) and one of the most commonly diagnosed cancers among women living with HIV (WLWH). These women face higher risks of HPV exposure due to sexual behavior and often encounter economic, social, and psychological barriers to screening. HIV and HPV co-infection can potentially accelerate CC carcinogenesis, with WLWH typically being diagnosed with CC earlier than their HIV-negative counterparts. Antiretroviral therapy (ART), which reduces AIDS-related mortality, also lowers the risk of invasive CC. The interaction between HIV and HPV is intricate and bidirectional. This summary reviews current evidence on HPV infection and CC in WLWH, highlighting the connections across pathogenesis, prevention, diagnosis, and treatment. Full article
(This article belongs to the Special Issue Advanced Research on HIV Virus and Infection)
Show Figures

Figure 1

Figure 1
<p>Interplay between HIV and HPV in cervical cancer development.</p>
Full article ">
Back to TopTop